The fixed - dose drug combination ombitasvir / paritaprevir / ritonavir (trade name Viekirax) has been available since January 2015 for the treatment of adults with chronic hepatitis C infection. (sciencedaily.com)
In two studies appearing in the May 5 issue of JAMA, patients with chronic hepatitis C virus (HCV) genotype 1 infection and with or without cirrhosis achieved high rates of sustained virologic response after 12 weeks of treatment with a combination of the direct - acting - antiviral drugs daclatasvir, asunaprevir, and beclabuvir. (sciencedaily.com)
IFN - α (alpha) forms are widely used in the treatment of chronic hepatitis C virus (HCV) infections and some forms of cancer. (thyroidpharmacist.com)